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Celiac disease (CD) diagnosis can be extremely challenging in the case of atypical patterns. In this context, oral signs seem to play
a decisive role in arousing suspicion of these forms of the disease. At the same time, the different expressions of the HLA-DQB1∗02
allele apparently seem to facilitate the interpretation of signs and highlighted symptoms.The aim of this work was to verify whether
it is possible to identify a correlation between the development of oral signs and differentDQ2haplotypes in celiac pediatric patients.
44 celiac patients with amedium age of 9.9 were studied. Oral examinations were performed in order to identify recurrent aphthous
stomatitis (RAS) and dental enamel defects (DED). The diagnosis of DED resulted as being related to allele expression (𝑃 value =
0.042) while it was impossible to find a similar correlation with RAS. When both oral signs were considered, there was an increase
in correlation with HLA-DQB1∗02 expression (𝑃 value = 0.018). The obtained results identified both the fundamental role that
dentists can play in early diagnosis of CD, as well as the possible role of HLA haplotype analysis in arousing suspicion of atypical
forms of the disease.
1. Introduction
Celiac disease (CD) is a complex pathologic condition involv-
ing the small intestine mucosa resulting from intolerance to
gluten assumption [1]. More specifically, it is considered a
genetic and autoimmune condition that can affect patients of
any age and gender with a great variability of symptoms and
clinical signs. Although the final diagnosis of CD is always
based on a biopsy with the detection of severe villous atro-
phy coupled with crypt hyperplasia, the diagnostic pathway
leading to this conclusion can often be long and winding
[1, 2]. This pathology, initially considered as typical of the
European population, is nowadays distributed worldwide.
Epidemiological analysis has reported a prevalence of celiac
disease as varying greatly between thewestern and the eastern
parts of the world, so that CD is today considered as the
most common genetic disorder in the west with a prevalence
of 1%, while it is relatively unknown in Asian countries
[1, 3]. This irregular distribution in different countries has
been related to genetic and alimentary factors. CD is actually
an intestinal enteropathywhose symptoms are determined by
the ingestion of gliadin in genetically predisposed patients [1].
Gliadin is a prolamin, a class of peptides highly resistant to
gastrointestinal enzymes, which causes histological changes
in the small intestine mucosa of the celiac patient, leading
to a malabsorption syndrome. This abnormal response of
the intestinal mucosa is linked to a specific genetic pre-
disposition; almost all the patients affected by CD carry a
HLA-DQ2 molecule which is highly frequent in the west
and absent in Asian countries. Infections represent another
environmental factor identified in the understanding of the
CD pathogenesis: the presence of different virus has been
described by several authors as a possible cause of pathology
development after gluten introduction in the diet [1, 4, 5].
The pathology can be clinically distinguished in different
forms, namely, classical, atypical, subclinical, and latent. The
classical form is characterized by the typical gastroenterolog-
ical signs related to the response of the intestinalmucosa after
exposure to gliadin. Atypical forms are describedwith several
symptoms and signs in various districts. The oral cavity is
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an area which is highly affected by extraintestinal signs of the
celiac disease, so that lesions in the oral mucosa or defects
in dental enamel may often be the only presenting features
of the atypical pattern [6–9]. The HLA haplotype was shown
to have a strong effect on the distribution of typical and
atypical signs. A previous work by Erriu et al. in 2011 related
the distribution of recurrent aphthous stomatitis (RAS) and
dental enamel defects (DED) in the oral cavity, in both child
and adult celiac patients, to the presence or absence of the
HLA-DQB1∗02 allele [10]. Enamel defects in children were
also analysed in another study in 2010 byMajorana et al., who
reported the absence of correlation between DED formation
and the expression of HLA-DR and -DQ alleles [11].
Based on the correlation detected in the previous 2011
paper between theHLA-DQB1∗02 haplotype and oral signs in
patients of all ages, the aim of this work was to verify whether
the same evidence can be confirmed in pediatric patients.
2. Material and Methods
2.1. Subjects. 44 celiac patients (16 males and 28 females)
were analysed, with a medium age of 9.9 years (range 6–
16 years), all typed for anti-gluten antibodies (AGA, both
IgA and IgG) and the anti-endomysial antibody (EMA). The
pathology had been diagnosed for each patient after small
bowel biopsy with positivity for enteropathy with Marsh
type 3 villous atrophy. Patients with type 1 or 2 intestinal
damage were excluded. Furthermore, all patients responded
to a gluten-free diet, as evaluated during further regular
annual followups. Anamnestic and diagnostic case studies
were compiled for each patient to indicate the past or current
presence of celiac oral signs, such as RAS and DED [9, 12,
13]. DED were graded from 0 to IV according to Aine’s
classification [14–16] while RAS linked toCDwas determined
by the investigation of past experience of aphthous lesions,
described by the patients as the contemporaneous presence
of one or more ulcers recurring at least twice a month in
the period preceding the gluten-free diet and which were not
reported 1 month after the start of the diet. The presence of
these lesions was verified by evaluating the medical records
of the patient’s first admission.
An agreement form explaining the aim and the charac-
teristics of the study was read and signed by the participants’
parents, and an identifying code was assigned to each subject
according to Italian privacy laws.The researchwas conducted
in accordance with Declaration of Helsinki research ethics.
Oral brushing was subsequently carried out on all patients,
obtaining a sample for DNA extraction allowing the deter-
mination of the HLA-DQB1 haplotype using a conventional
polymerase chain reaction (PCR) method [17].
All clinical data and samples were obtained from routine
testing and visits carried out at the hospital where CD
diagnosis had been performed. No new visits or sampling
were carried out on patients in order to perform this study.
2.2. PCR Technique and Determination of HLA-DQB1 Geno-
type. The kit constituted of a preformed MIX, and eight
couples of primers were used in order to perform the
molecular analysis. Positivity or negativity of amplification
for each couple allowed theHLA-DQB1 genotype to be estab-
lished [9, 12, 13]. This set of primers can positively identify
the HLA-DQB1 alleles corresponding to the serologically
defined seriesHLA-DQ2,DQ3,DQ4,DQ5,DQ6,DQ7,DQ8,
and DQ9; thus, all combinations of DQB1 can be readily
identified. DQ4, DQ5, and DQ6 were uniquely identified,
whereasDQ2 specificity was amplified by three primermixes,
DQ7 and DQ9 specificities were amplified by two primer
mixes, and DQ3 and DQ8 specificities were amplified by four
primer mixes.
On the contrary, on examining the eight primer mixes
with the corresponding amplified DQB1 alleles, the first
primer mix amplified allele group DQB1∗05, the second
amplified allele groupDQB1∗06, the third, the fourth, and the
sixth amplified allele groupDQB1∗02, the fourth, the fifth, the
sixth, and the seventh amplified allele group DQB1∗03, and
the eighth amplified allele group DQB1∗04.
For all the alleles, the reaction was performed in 10.08 𝜇L
reaction volumes using the mixture according to the manu-
facturer’s instructions. The mixture contained 3 𝜇L of mas-
ter mix, 5 𝜇L of DNAsi-RNAsi free water, 0.08𝜇L of Taq
polymerase, and 2 𝜇L of DNA suspension, and this was
put into a tube containing the lyophilized primer pair. The
thermocycler profile was performed as follows: an initial
denaturation at 94∘C for 2min, 10 cycles consisting of 94∘C
for 10 sec and 65∘C for 1min, and finally 20 cycles consisting
of 94∘C for 10 sec, 61∘C for 1min, and 72∘C for 30 sec. PCR
products were analysed by electrophoresis on an agarose gel.
2.3. Statistical Analysis. Descriptive statistics, Fisher’s exact
test, and binary logistic regression analysis were performed.
To test the relation between the HLA haplotype and the
presence of oral signs, a logit regression model was used
where the outcome variable represents the presence (or the
absence) of the specific oral sign to be tested (DED, RAS,
or both). A variable was then coded with values 0, 1, or
2 if the individual carried no, one, or two copies of the
HLA-DQB1∗02 allele, respectively. Values of 𝑃 < 0.05 were
considered as significant.
3. Results
According to the clinical evaluation, the result of the patients
affected by RAS was 18.2% (8 persons), while a DED was
diagnosed for 38.6% of the patients (17 persons), with 52.3%
(23 persons) presenting one or more oral signs (Figure 1).
HLA-DQB1∗02 distribution showed similarities with the
previous work by Erriu et al. [10] (Table 1, Figure 1). The
percentage of patients carrying two copies of the alleles was
38.6%, and 40.9% showed heterozygosis while only 20.5% did
not carry the allele.
DED diagnosis resulted as being related to the presence
or absence of the allele (𝑃 value = 0.042). On the contrary,
it was not possible to find a similar correlation with RAS (𝑃
value = 0.084).When considering both oral signs, correlation
with HLA-DQB1∗02 expression increased with a highly
significant 𝑃 value (𝑃 value = 0.018) (Table 2, Figure 2).
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Table 1
HLA-DQB1∗02 homozygosis HLA-DQB1∗02 heterozygosis HLA-DQB1∗02 absence Trials
Previous study [10] 33 47 18 98
Current study 17 18 9 44
𝑃 value 0.574 0.471 0.819
38,8%
61,2%
(previous study)
RAS and/or DED frequency
47,7%
52,3%
81,8%
18,2%
61,4%
38,6%
RAS and/or DED frequency
Unaffected
Affected
Unaffected
Affected
DED frequency RAS frequency
Figure 1
4. Discussion
Clinical manifestations of CD are variable, depending on
the form of the disease. Classical CD is normally diagnosed
at a young age, according to the easy recognition of the
characteristic signs and symptoms. On the contrary, atypical
forms can, in some cases, be hard to detect, making early
diagnosis difficult to perform [18]. The awareness of the
complications of the late diagnosis of celiac disease makes
it necessary to establish guidelines allowing the clinician to
suspect the disease early, even in the case of atypical forms.
For this reason, extraintestinal symptoms have recently
assumed increasing importance in order to arouse suspicion
of CD. Oral signs have been described by several authors
as diagnostic elements of frequent detection in the course
of atypical disease [19]. DED and RAS frequency appears to
be variable from study to study, in relation to the age of the
patients, the geographical area, and environmental factors. A
study by Bucci et al. in 2006 looked for a difference in the
distribution of DED and RAS in 72 celiac patients compared
with 162 healthy subjects.They described a prevalence of 20%
of DED in celiac patients (against the 5.6% of the controls)
while no statistical differences were found for RAS. In this
study, 33.3% of the celiac patients showed oral ulcers against
23.4% of the controls [20]. In 2010, Costacurta et al. reported
a frequency of 33.3% of DED and 8.3% of RAS in an Italian
population of 300 celiac patients with a mean age of 8.16
years compared with a cohort of 300 healthy subjects [21].
In this study the authors described a statistically relevant
difference between the two groups. A reviewpublished in 2011
by Rashid et al. described the prevalence of DED in patients
with permanent teeth, as ranging between 9.5% and 95.9%
(mean 51.1%) [9, 22]. In the same study, RAS frequency was
based on a Canadian study which described patients with
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Table 2
Copies of HLA-DQB1∗02 𝑁 patients 𝑁 affected 𝑁 unaffected Affected % Unaffected in % OR (CI 95%)
𝑃 value
DED
0 9 8 1 88.9% 11.1%
0.40 (0.17–0.97)
0.0421 18 3 15 16.7% 83.3%
2 17 6 11 35.3% 64.7%
RAS
0 9 3 6 33.3% 66.7%
0.38 (0.13–1.14)
0.0841 18 4 14 22.2% 77.8%
2 17 1 16 5.9% 94.1%
DED and/or RAS
0 9 9 0 100.0% 0.0%
0.33 (0.13–0.82)
0.0181 18 7 11 38.9% 61.1%
2 17 7 10 41.2% 58.8%
47,6%
52,4%
30,45%
30,45%
39,1%
Unaffected
Affected
DED and/or RAS
HLA-DQB1∗02 absence
HLA-DQB1∗02 heterozygosis
HLA-DQB1∗02 homozygosis
Figure 2
this sign, aged less than 16 years old, in 16% of the cases,
while adult patients had reported recurrent oral ulcers in 26%
of the cases [23, 24]. In 2008 Campisi et al. analysed the
frequency of RAS in a group of 269 Italian celiac patients
aged from 3 to 17 compared with a control group of 575
clinically healthy subjects. Their analysis identified a RAS
frequency of 22.7% in the patients with CD against the 7.1%
of the control group [25]. In 2011 Erriu et al. described the
frequency of DED and RAS in a population of 98 celiac
patients. In this work DED were identified in 28.6% of the
cases and RAS in 38.8% of the patients [10]. In 2012 Yas¸ar et
al. studied the prevalence of RAS in a cohort of 82 patients
in Istanbul and identified the patients affected by RAS before
esophagogastroduodenoscopy. Their results showed that the
prevalence of CD in the RAS population did not significantly
differ from that of the unaffected matched population [26].
In the same year El-Hodhod et al. performed a similar study,
evaluating 140 Egyptian patients with DED, aged 4–12, while
the control group was represented by 720 healthy children.
From their analysis, celiac disease was diagnosed in 25% of
the patients with DED, against the 0.97% of the control group
[27].
The prevalence of oral signs in this paper resulted as being
similar to that highlighted in the literature. In fact, DEDwere
identified in 38.6% of the cases while RAS was observed in
18.2% of the patients. In comparison with the previous work
performed in 2011, it was possible to identify a reduction of
the cases of RAS [10].This could be explained by the fact that
some cases of RAS could have passed unobserved due to the
gluten-free diet started in early childhood.
This high variability in the prevalence of the oral signs
was analysed in 2011 in the study by Erriu et al. which
showed a statistically significant correlation between oral
manifestations andHLA expression [10]. In the present study
this correlation resulted statistically confirmed in the younger
patients. The HLA-DQB1∗02 allele has a fundamental
influence on the pathogenesis of CD. The study by Jores
et al. showed a positive association between an increasing
frequency of DQB1∗0201 allele homozygosis and the severity
of intestinal damage [28]. On the contrary, an only partially
explained negative association does seem to exist in the oral
cavity.The hypothesis elaborated in 2011 has not yet been ade-
quately detailed in order to reach a conclusive observation.
Both the histological diversity of oral and intestinal mucosa,
such as the different oral bacterial flora, as well as a reaction
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related to additional stimuli typical of the oral cavity, could
all be possible responses to the phenomena described [10].
5. Conclusions
Theneed of an early diagnosis for all the forms of CD is still an
open challenge.This study has shown how the role of dentists
in identifying atypical patterns could be fundamental. In
particular, the presence of oral signs could be very important
for detection in the youngest patients, avoiding the several
complications related to CD in adulthood.
Authors’ Contribution
M. Erriu and G. M. Abbate equally contributed to this work.
References
[1] N. Gujral, H. J. Freeman, and A. B. Thomson, “Celiac disease:
prevalence, diagnosis, pathogenesis and treatment,”World Jour-
nal of Gastroenterology, vol. 18, no. 42, pp. 6036–6059, 2012.
[2] D. Schuppan, Y. Junker, and D. Barisani, “Celiac Disease: from
pathogenesis to novel therapies,” Gastroenterology, vol. 137, no.
6, pp. 1912–1933, 2009.
[3] P. H. R. Green and C. Cellier, “Medical progress: celiac disease,”
The New England Journal of Medicine, vol. 357, no. 17, pp. 1731–
1743, 2007.
[4] C. Ruggeri, A. T. laMasa, S. Rudi et al., “Celiac disease and non-
organ-specific autoantibodies in patients with chronic hepatitis
C virus infection,”Digestive Diseases and Sciences, vol. 53, no. 8,
pp. 2151–2155, 2008.
[5] L. C. Stene, M. C. Honeyman, E. J. Hoffenberg et al., “Rotavirus
infection frequency and risk of celiac disease autoimmunity
in early childhood: a longitudinal study,” American Journal of
Gastroenterology, vol. 101, no. 10, pp. 2333–2340, 2006.
[6] M. Erriu, F. Canargiu, G. Orru, V. Garau, and C. Montaldo,
“Idiopathic atrophic glossitis as the only clinical sign for celiac
disease diagnosis: a case report,” Journal of Medical Case
Reports, vol. 6, no. 1, article 185, 2012.
[7] J. Cheng, T. Malahias, P. Brar, M. T. Minaya, and P. H. R. Green,
“The association between celiac disease, dental enamel defects,
and aphthous ulcers in a United States cohort,” Journal of
Clinical Gastroenterology, vol. 44, no. 3, pp. 191–194, 2010.
[8] P. C. D. Silva, P. D. V. de Almeida,M. Aˆ. N.Machado et al., “Oral
manifestations of celiac disease. A case report and review of the
literature,” Medicina Oral, Patologia Oral y Cirugia Bucal, vol.
13, no. 9, pp. E559–E562, 2008.
[9] L. Pastore, A. Carroccio,D. Compilato, V. Panzarella, R. Serpico,
and L. L. Muzio, “Oral manifestations of celiac disease,” Journal
of Clinical Gastroenterology, vol. 42, no. 3, pp. 224–232, 2008.
[10] M. Erriu, S. Sanna, A. Nucaro, G. Orru`, V. Garau, and C.
Montaldo, “HLA-DQB1 haplotypes and their relation to oral
signs linked to celiac disease diagnosis,”OpenDentistry Journal,
vol. 5, no. 1, pp. 174–178, 2011.
[11] A. Majorana, E. Bardellini, A. Ravelli, A. Plebani, A. Pol, and G.
Campus, “Implications of gluten exposure period, CD clinical
forms, andHLA typing in the association between celiac disease
and dental enamel defects in children. A case-control study,”
International Journal of Paediatric Dentistry, vol. 20, no. 2, pp.
119–124, 2010.
[12] J. Cheng, T. Malahias, P. Brar, M. T. Minaya, and P. H. R.
Green, “The association between celiac disease, dental enamel
defects, and aphthous ulcers in a United States cohort,” Journal
of Clinical Gastroenterology, vol. 44, no. 3, pp. 191–194, 2010.
[13] L. Pastore, G. Campisi, D. Compilato, and L. L. Muzio, “Orally
based diagnosis of celiac disease: current perspectives,” Journal
of Dental Research, vol. 87, no. 12, pp. 1100–1107, 2008.
[14] A. Ballinger, C. Hughes, P. Kumar, I. Hutchinson, andM. Clark,
“Dental enamel defects in coeliac disease,”The Lancet, vol. 343,
no. 8891, pp. 230–231, 1994.
[15] C. D. Wierink, D. E. van Diermen, I. H. A. Aartman, and H.
S. A. Heymans, “Dental enamel defects in children with coeliac
disease,” International Journal of Paediatric Dentistry, vol. 17, no.
3, pp. 163–168, 2007.
[16] L. Aine, M. Maki, O. Keyrilainen, and P. Collin, “Dental
enamel defects in celiac disease,” Journal of Oral Pathology and
Medicine, vol. 19, no. 6, pp. 241–245, 1990.
[17] M. Erriu, F. Boscarelli, C. Peluffo et al., “A rapid sample method
for HLA haplotype typization. A preliminary study on celiac
patients,” Minerva Stomatologica, vol. 59, no. 9, pp. 477–487,
2010.
[18] B. Admou, L. Essaadouni, K. Krati, K. Zaher, M. Sbihi, L.
Chabaa et al., “Atypical celiac disease: from recognizing to
managing,” Gastroenterology Research and Practice, vol. 2012,
Article ID 637187, 9 pages, 2012.
[19] L. Pastore, M. de Benedittis, M. Petruzzi et al., “Importance of
oral signs in the diagnosis of atypical forms of celiac disease,”
Recenti Progressi in Medicina, vol. 95, no. 10, pp. 482–490, 2004.
[20] P. Bucci, F. Carile, A. Sangianantoni, F. D’Angio`, A. Santarelli,
and L. L. Muzio, “Oral aphthous ulcers and dental enamel
defects in children with coeliac disease,” Acta Paediatrica, vol.
95, no. 2, pp. 203–207, 2006.
[21] M. Costacurta, P. Maturo, M. Bartolino, and R. Docimo, “Oral
manifestations of coeliac disease: a clinical-statistic study,”
Journal of Oral Implantology, vol. 3, no. 1, pp. 12–19, 2010.
[22] M. Rashid, M. Zarkadas, A. Anca, and H. Limeback, “Oral
manifestations of celiac disease: a clinical guide for dentists,”
Journal of the Canadian Dental Association, vol. 77, article b39,
2011.
[23] M. Rashid, A. Cranney, M. Zarkadas et al., “Celiac disease:
evaluation of the diagnosis and dietary compliance in Canadian
children,” Pediatrics, vol. 116, no. 6, pp. e754–e759, 2005.
[24] A. Cranney, M. Zarkadas, I. D. Graham et al., “The Canadian
Celiac Health Survey,” Digestive Diseases and Sciences, vol. 52,
no. 4, pp. 1087–1095, 2007.
[25] G. Campisi, C. di Liberto, A. Carroccio et al., “Coeliac disease:
oral ulcer prevalence, assessment of risk and association with
gluten-free diet in children,”Digestive and Liver Disease, vol. 40,
no. 2, pp. 104–107, 2008.
[26] S¸. Yas¸ar, B. Yas¸ar, E. Abut, and Z. As¸iran Serdar, “Clinical
importance of celiac disease in patients with recurrent aphthous
stomatitis,”Turkish Journal of Gastroenterology, vol. 23, no. 1, pp.
14–18, 2012.
[27] M. A. El-Hodhod, I. A. El-Agouza, H. Abdel-Al, N. S. Kabil,
and K. A. Bayomi, “Screening for celiac disease in children with
dental enamel defects,” ISRN Pediatrics, vol. 2012, Article ID
763783, 7 pages, 2012.
[28] R.-D. Jores, F. Frau, F. Cucca et al., “HLA-DQB1∗0201 homozy-
gosis predisposes to severe intestinal damage in celiac disease,”
Scandinavian Journal of Gastroenterology, vol. 42, no. 1, pp. 48–
53, 2007.
Submit your manuscripts at
http://www.hindawi.com
Stem Cells
International
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
MEDIATORS
INFLAMMATION
of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Behavioural 
Neurology
Endocrinology
International Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Disease Markers
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
BioMed 
Research International
Oncology
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Oxidative Medicine and 
Cellular Longevity
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
PPAR Research
The Scientific 
World Journal
Hindawi Publishing Corporation 
http://www.hindawi.com Volume 2014
Immunology Research
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Journal of
Obesity
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
 Computational and  
Mathematical Methods 
in Medicine
Ophthalmology
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Diabetes Research
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Research and Treatment
AIDS
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Gastroenterology 
Research and Practice
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Parkinson’s 
Disease
Evidence-Based 
Complementary and 
Alternative Medicine
Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com
